期刊文献+

SiRNA逆转肺耐药相关蛋白表达介导的白血病细胞多药耐药

Reversal of muti-drug resistance in leukemia cells induced by lung resistance-related protein by short interfering RNA
下载PDF
导出
摘要 目的:研究双链短干扰RNA(siRNA)对白血病多药耐药细胞模型(K562/NaB)肺耐药相关蛋白(LRP)表达及功能的影响.方法:针对LRP基因设计合成特异性siRNA,在脂质体介导下转染K562/NaB;采用半定量逆转录聚合酶链反应(RT-PCR)检测K562细胞LRP mRNA的水平;用流式细胞术检测K562/NaB细胞LRP蛋白表达的变化和细胞内柔红霉素(DNR)的蓄积;MTT法检测阿霉素(ADM)对K562/NaB细胞耐药的半数抑制浓度(IC50).结果:siRNA转染后:K562/NaB细胞的LRPmRMA水平明显降低;LRP蛋白表达由阳性转为阴性;细胞内DNR的蓄积明显增加,DNR平均荧光增强3.28倍;对ADM药物敏感相对逆转效率为78.18%.结论:siRNA可逆转由LRP介导的白血病细胞多药耐药. AIM: To investigate the effect of short interfering RNA (siRNA) on expression and function of lung resistancerelated protein (LRP) in the multi-drug resistant human leukemia cells (K562/NaB). METHODS: Multidrug-resistant K562 cells with high level LRP expression treated with sodium butyrate (NaB), was used as an in vitro model system. LRP specific siRNA was synthesized and transfected into the K562/NaB cells. Expression of LRP mRNA was detected by reverse transcriptasepolymerase chain reaction ( RT-PCR), and protein level and intracellular daunorubicin (DNR) accumulation in K562/NaB cells were detected by flow cytometry. 50% inhibition concentration (IC50) of adriamycin ( ADM ) on K562/NaB cells was detected by MTY method. RESULTS: LRP mRNA level was decreased obviously; the protein expression was turned from positive result to negative result. Intracellular DNR accumulation was increased and the mean fluorescence of DNR was 3.28 times higher. The relative efficiency to ADM was 78.18%. CONCLUSION: The siRNA could effectively reverse the multi-drug resistance of leukemia cells induced by LRP.
出处 《第四军医大学学报》 北大核心 2007年第20期1851-1854,共4页 Journal of the Fourth Military Medical University
基金 广州市科技计划项目(2002J1-C0031)
关键词 RNA 小分子干扰 基因 肺耐药相关蛋白 K562细胞 抗药性 多药 RNA, small interfering gene, lung resistancerelated protein K562 cells drug resistance, multiple
  • 相关文献

参考文献10

  • 1List AF,Spier CS,Grogan TM,et al.Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia[J].Blood,1996,87:2464 -2469.
  • 2Volm M,Stammler G,Zintl F,et al.Expression of lung resistancerelated protein (LRP) in initial and relapsed childhood acute lymphoblastic leukemia[J].Anticancer Drugs,1997,8:662 -665.
  • 3Fire A,Xu S,Montgomery MK,et al.Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans[J].Nature,1998,391:806-811.
  • 4Zamore PD.RNA interference:listening to the sound of silence[J].Nat Struct Biol,2001,8:746 -750.
  • 5李宁,钱新华,姚英民,王志远.丁酸钠诱导人慢性髓系白血病K562细胞肺耐药相关基因蛋白的表达[J].癌症,2003,22(8):821-825. 被引量:3
  • 6Elbashir SM,Harborth J,Lendeckel W,et al.Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells[J].Nature,2001,411:494 -498.
  • 7Caplen NJ,Parrish S,Imani F,et al.Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems[J].Proc Natl Acad Sci U S A,2001,98:9742-9747.
  • 8Harborth J,Elbashir SM,Bechert K,et al.Identification of essential genes in cultured mammalian cells using small interfering RNAs[J].J Cell Sci,2001,114:4557 -4565.
  • 9Scherr M,Battmer K,Winkler T,et al.Specific inhibition of bcr-abl gene expression by small interfering RNA[J].Blood,2003,101:1566-1569.
  • 10彭智,肖志坚,王一,刘澎,蔡英林,冯文莉,韩忠朝.siRNA逆转K562/A02细胞多药耐药的研究[J].中华血液学杂志,2004,25(1):5-7. 被引量:42

二级参考文献20

  • 1Lange C, Walther W, Schwabe H, et al. Cloning and initial analysis of the human muhidrug resistance-related MVP/LRP gene promoter [J] . Biochem Biophys Res Commun, 2000, 278 (1):125 - 133.
  • 2Kitazono M, Sumizawa T, Takebayashi Y, et al. Muhidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells [J]. J Natl Cancer Inst, 1999, 91 (19):1647 - 1653.
  • 3Scheper RJ, Broxterman HJ, Schcffer GL, et al. Overexpression of a M(r) 110, 000 vescular protein in non-P-glycoprotein-mediated multidrug resistance [J ]. Cancer Res, 1993, 53 (7) : 1475 - 1479.
  • 4Laurencot CM, Scheffer GL, Scheper RJ, et al. Increased LRP mRNA expression is associated with the MDR phenotype in intrinsically resistant human cancer cell lines [J]. Int J Cancer,1997, 72(6): 1021 - 1026.
  • 5Izquierdo MA, Neefjes JJ, Mathari AE, et al. Relationship of LRP-human major vault protein to in vitro and clinical resistance to anticancer drugs [J]. Cytotechnology, 1996,19(3): 191 - 197.
  • 6Dalton WS, Scheper RJ. Lung resistance-related protein:determining its role in muhidrug resistance [J]. J Natl Cancer Inst, 1999, 91 ( 19): 1604 - 1605.
  • 7Filipits M, Stranzl T, Pohl G, et al. Drug resistance factors in acute myeloid leukemia: a comparative analysis [J]. Leukemia, 2000,14(1):68 -76.
  • 8Ogretmen B, Barredo JC, Safa AR. Increased expression of lung resistance-related protein and multidrug resistance-associated protein messenger RNA in childhood acute lymphoblastic leukemia[ J ]. J Pediatr Hematol Oncol, 2000, 22 ( 1 ) : 45 - 49.
  • 9Den Boer ML, Pieters R, Kazemier KM, et al. Relationship between major vault protein/lung resistance protein, muhidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia [J]. Blood, 1998, 91 (6): 2092 -2098.
  • 10Volm M, Stammler G, Zintl F, et al. Expression of lung resistance-related protein(LRP) in initial and relapsed childhood acute lymphoblastic leukemia [J]. Anticancer Drugs, 1997, 8(7):662 - 665.

共引文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部